发明名称 cristal, droga, e, uso de um cristal
摘要 The present invention relates to a crystal of 1-ethyl-7-methyl-3-{4-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)oxy]phenyl}-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one useful as a prophylactic or therapeutic agent for schizophrenia and the like, which shows an X-ray powder diffraction pattern having characteristic peaks at interplaner spacings (d) of 13.59 plus or minus 0.2 and 6.76 plus or minus 0.2 Angstroms in powder X-ray diffraction.
申请公布号 BR112013032052(A2) 申请公布日期 2016.12.13
申请号 BR20131132052 申请日期 2012.06.21
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 KATSUHIKO YAMAMOTO
分类号 C07D471/04;A61K31/437;A61P25/18 主分类号 C07D471/04
代理机构 代理人
主权项
地址